Guangzhou Baiyunshan Pharmaceutical Holdings Ltd 2022 Annual Report with Sustainability Disclosures
Company: Guangzhou Baiyunshan Pharmaceutical Holdings Ltd
Sector: Manufacturing
Country: China
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 391
The report presents consolidated 2022 operating income of RMB70,788,155,068.45 and notes 193 products in research. It reports 24,249 employees across the Company and major subsidiaries. Environmental and social disclosures describe clean-energy boiler use, energy-saving equipment and preparation of a separate 2022 Social Responsibilities Report.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.